Canada Markets closed

Caladrius Biosciences, Inc. (CLBS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7751-0.0230 (-2.88%)
At close: 04:00PM EST
0.7400 -0.04 (-4.53%)
After hours: 07:43PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.0500
52 Week Low 30.7600
50-Day Moving Average 30.9330
200-Day Moving Average 31.2759

Share Statistics

Avg Vol (3 month) 3718.68k
Avg Vol (10 day) 32.17M
Shares Outstanding 559.78M
Implied Shares Outstanding 6N/A
Float 846.06M
% Held by Insiders 13.66%
% Held by Institutions 130.77%
Shares Short (Dec. 14, 2021) 4997.21k
Short Ratio (Dec. 14, 2021) 42.64
Short % of Float (Dec. 14, 2021) 41.69%
Short % of Shares Outstanding (Dec. 14, 2021) 41.67%
Shares Short (prior month Nov. 14, 2021) 41.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul. 27, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul. 27, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.91%
Return on Equity (ttm)-38.42%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -27.58M
Net Income Avi to Common (ttm)-26.1M
Diluted EPS (ttm)-0.5770
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)100.15M
Total Cash Per Share (mrq)1.67
Total Debt (mrq)350k
Total Debt/Equity (mrq)0.36
Current Ratio (mrq)25.08
Book Value Per Share (mrq)1.65

Cash Flow Statement

Operating Cash Flow (ttm)-23.21M
Levered Free Cash Flow (ttm)-16.49M